ID   SG231
AC   CVCL_0519
SY   PCI:SG231; PCI-SG231; PCI:SG-231
DR   BTO; BTO:0002935
DR   MCCL; MCC:0000417
DR   ATCC; CRL-2126
DR   BioSample; SAMN03472551
DR   cancercelllines; CVCL_0519
DR   Cell_Model_Passport; SIDM01852
DR   DepMap; ACH-001857
DR   Wikidata; Q54953156
RX   CelloPub=CLPUB00275;
RX   PubMed=2176543;
RX   PubMed=27231123;
RX   PubMed=35640676;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Thr125Pro (c.373A>C); ClinVar=VCV000376666; Zygosity=Unspecified (DepMap).
CC   Omics: Deep exome analysis.
CC   Discontinued: ATCC; CRL-2126; true.
ST   Source(s): ATCC; DepMap
ST   Amelogenin: X
ST   CSF1PO: 10 (ATCC)
ST   CSF1PO: 10,11 (DepMap)
ST   D13S317: 9,10
ST   D16S539: 9,14 (DepMap)
ST   D16S539: 14 (ATCC)
ST   D18S51: 18
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 21,21.2
ST   Penta D: 12,15
ST   Penta E: 10,13
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 22
//
RX   CelloPub=CLPUB00275;
RA   Zach S., Birgin E., Ruckert F.;
RT   "Primary cholangiocellular carcinoma cell lines.";
RL   J. Stem Cell Res. Transplant. 2:1013-1013(2015).
//
RX   PubMed=2176543; DOI=10.1002/gcc.2870020408;
RA   Storto P.D., Saidman S.L., Demetris A.J., Letessier E.,
RA   Whiteside T.L., Gollin S.M.;
RT   "Chromosomal breakpoints in cholangiocarcinoma cell lines.";
RL   Genes Chromosomes Cancer 2:300-310(1990).
//
RX   PubMed=27231123; DOI=10.1158/2159-8290.CD-15-1442;
RA   Saha S.K., Gordan J.D., Kleinstiver B.P., Vu P., Najem M.S., Yeo J.-C.,
RA   Shi L., Kato Y., Levin R.S., Webber J.T., Damon L.J., Egan R.K.,
RA   Greninger P., McDermott U., Garnett M.J., Jenkins R.L.,
RA   Rieger-Christ K.M., Sullivan T.B., Hezel A.F., Liss A.S., Mizukami Y.,
RA   Goyal L., Ferrone C.R., Zhu A.X., Joung J.K., Shokat K.M., Benes C.H.,
RA   El-Bardeesy N.;
RT   "Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity
RT   and SRC dependence in intrahepatic cholangiocarcinoma.";
RL   Cancer Discov. 6:727-739(2016).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//